Statement Showing Status On Investors' Complaint For The Quarter Ended June 30, 2017
Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we are forwarding herewith status on investors' Complaint for the quarter ended June 30, 2017. Shareholding for the Period Ended June 30, 2017
Himadri Speciality Chemical Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that Analyst/Investor meetings are scheduled and following are the details. Date Place Type of Meeting 30 June 2017 Mumbai One-on-One & Group This is to further inform that the copy of Investor Update has been uploaded on the website of the Company www.himadri.com and is also available... Transcript Analyst/ Investor Conference Call
This has reference to our letter Ref No. HSCL / Stock-Ex/2017-18/020 dated 10 May, 2017 regarding the Conference Call, and pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,weare enclosing herewith the copy of the transcript of the Conference call held on Friday the 12th May 2017. The same is also available on the website of the Company i.e. www.himadri.com. Press Release
Dear Sir, We are enclosing herewith:- 1.Investors presentation 2.Media/Press Release We request you to kindly take on record the same. Intimation For Conference Call Under Regulation 30 Of SEBI (LODR) Regulation, 2015
Intimation pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III thereof, is hereby given that the Company proposes to hold a conference call with Institutional Investors/Analysts to discuss the Audited financial results of the Company for the quarter and year ended 31 March 2017. The details of the subject conference call are as under:- Date and... Board recommends Dividend
Himadri Speciality Chemical Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2017, inter alai, has recommended a dividend Re. 0.10 per share (@10%) per equity share of Re. 1/- each. Board to consider Dividend
Sub: Regulation 30 of SEBI (LODR) Regulations, 2015)-Recommendation of Dividend Dear Sir, Pursuant to Regulation 30 of the SEBI(LODR) Regulation, 2015, this to inform you that subject to the approval shareholders, the Board at its' meeting held today i.e, 10th May 2017, has recommended a dividend of Re 0.10 per share (@10%) per equity share having face value of Re 1/- each for the Financial Year 2016-17. The above dividend, if declared... Outcome of Board Meeting
Dear Sir, This to inform you that the Board at its' meeting held on Wednesday the 10th May 2017, inter-alia has approved and taken record the Audited Financial Results (Standalone & Consolidated) alongwith Statement of Assets and Liabilities for the Financial Year ended 31st March, 2017. Pursuant to Regulation 52 of the SEBI (LODR) Regulations, 2015, we are enclosing the following:- i)Statement showing the Audited Financial Results...